Pharma tries to recoup public trust

RSS
Stung by Public Distrust, Drug Makers Seek to Heal Image: "'The decision against Merck...is a clear statement that despite all the good our industry is doing, we're losing the battle for consumer trust,' says Arthur Higgins, chairman of Bayer Healthcare, a Bayer AG unit."


And they're working on it, but this will be a tough one to come back from—only 21 percent of people surveyed give pharma a favorable rating, according to the article in the Wall St. Journal (free for seven days).

Please or Register to post comments.

Blog Archive